Evolution from Primary Biliary Cirrhosis to Primary Biliary Cirrhosis/Autoimmune Hepatitis Overlap Syndrome

ABSTRACT

An asymptomatic 70-year-old Hispanic woman with type 2 diabetes was found in 2004 to have an AST of 132 U/L, ALT 146 U/L, alkaline phosphatase 1107 U/L, total serum bilirubin 3.5 mg/dL, and albumin 2.9 g/dL. Viral hepatitis testing was negative. Serum IgG, IgA, and IgM were all elevated, antimitochondrial antibody was weakly positive, and antinuclear antibody was negative. Liver biopsy was reported to show “evolving cirrhosis with marked lymphoid hyperplasia.” Although the indication was nowhere stated, she was prescribed ursodeoxycholic acid 500 mg b.i.d, on which her biochemical tests initially improved. One year later she developed itching and jaundice. Imaging studies revealed multiple gallstones. An MRCP was suggestive of cirrhosis with a questionable common bile duct stricture, and she underwent ERCP with removal of gallbladder and common bile duct stones and placement of a biliary stent. A periampullary mass, which proved to be a somatostatinoma, was excised in 2006 via an open laparotomy, at which the stent was removed and a second liver biopsy performed. It was reported as showing chronic active hepatitis, activity stage 2, and fibrosis grade 3 with bridging. Her subsequent course was complicated by recurrent bleeding from small bowel arteriovenous malformations. Seen for the first time at Columbia University Medical Center in January 2007, she complained of continuing pruritus. AST was 69 U/L, ALT 43 U/L, alkaline phosphatase 491 U/L, and total bilirubin 3.3 mg/dL. Serum albumin was 2.6 g/dL. Antinuclear antibodies, negative in 2004, were now positive at 1:320, and antimitochondrial M2 antibodies were strongly positive. Serum IgG and IgA, but not IgM, were elevated. Review of her outside liver biopsies revealed features of primary biliary cirrhosis (PBC) in the first, and of both PBC and autoimmune hepatitis (AIH) in the second. The patient exhibits an overlap syndrome, in which both histologic and serologic features of AIH evolved in a setting initially most suggestive of PBC alone. The phenomenon of autoimmune overlap syndromes is discussed.

KEYWORDS

Autoimmunity - autoantibodies - interface hepatitis - necroinflammation

REFERENCES

• 1 Czaja A J. Frequency and nature of the variant syndromes of autoimmune liver disease.  Hepatology. 1998;  28 360-365
• 2 Gossard A A, Lindor K D. Development of autoimmune hepatitis in primary biliary cirrhosis.  Liver Int. 2007;  27 1086-1090
• 3 Neuberger J. Primary biliary cirrhosis.  Lancet. 1997;  350 875-879
• 4 Addison T, Gull W. On a certain affection of the skin, Vitiligoidea-α plana, β tuberose: with remarks and plates.  Guys Hosp Rep. 1851;  7 265-276
• 5 Ahrens Jr E H, Payne M A, Kunkel H G, Eisenmenger W J, Blondheim S H. Primary biliary cirrhosis.  Medicine (Baltimore). 1950;  29 299-364
• 6 Delbet P. Retrecissement du choledoque cholecystoduodenostomie.  Bull Mem Soc Chir Paris. 1924;  50 1144-1146
• 7 Waldenström J. Blutproteine und Nahrungseiweiss.  Dtsch Z Verdau Stoffwechselkr. 1953;  9 113-119
• 8 Schramm C, Lohse A W. Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis.  Clin Rev Allergy Immunol. 2005;  28 105-114
• 9 Woodward J, Neuberger J. Autoimmune overlap syndromes.  Hepatology. 2001;  33 994-1002
• 10 Ben-Ari Z, Czaja A J. Autoimmune hepatitis and its variant syndromes.  Gut. 2001;  49 589-594
• 11 Czaja A J. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries.  J Hepatol. 2006;  44 251-252
• 12 Lohse A W, zum Buschenfelde K H, Franz B et al.. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals.  Hepatology. 1999;  29 1078-1084
• 13 Csepregi A, Obermayer-Straub P, Kneip S et al.. Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis.  Clin Dev Immunol. 2003;  10 173-181
• 14 Alvarez F, Berg P A, Bianchi F B et al.. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.  J Hepatol. 1999;  31 929-938
• 15 Papamichalis P A, Zachou K, Koukoulis G K et al.. The revised autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.  J Autoimmune Dis. 2007;  4 3
• 16 Poupon R, Chazouilleres O, Corpechot C et al.. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis.  Hepatology. 2006;  44 85-90
• 17 Joshi S, Cauch-Dudek K, Wanless I R et al.. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.  Hepatology. 2002;  35 409-413
• 18 Chazouilleres O, Wendum D, Serfaty L et al.. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.  J Hepatol. 2006;  44 400-406
• 19 van Leeuwen D J, Sood G, Ferrante D et al.. A 38-year-old African-American woman with an unusually rapid progression of “primary biliary cirrhosis”: a missed opportunity.  Semin Liver Dis. 2002;  22 395-406
• 20 Muratori P, Granito A, Pappas G et al.. Autoimmune liver disease 2007.  Mol Aspects Med. 2007;  , October 24 (Epub ahead of print)

1 United States Supreme Court, Jacobellis v Ohio, 378 U.S. 184 (1964)